Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, Par Value $0.001 Per Share
-
Shares outstanding
-
47M
-
Number of holders
-
276
-
Total shares
-
51.9M
-
Shares change
-
+2.91M
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
+$81.6M
-
Put/Call ratio
-
3.63
-
Number of buys
-
146
-
Number of sells
-
-109
-
Price
-
$28.61
Significant Holders of Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) as of Q2 2024
filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share as of Q2 2024.
Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) has 276 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.9M shares
.
Largest 10 shareholders include BlackRock Inc. (8.01M shares), VANGUARD GROUP INC (5.08M shares), Pacer Advisors, Inc. (2.16M shares), RENAISSANCE TECHNOLOGIES LLC (2.07M shares), STATE STREET CORP (1.9M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.84M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), MACQUARIE GROUP LTD (1.57M shares), Stephens Investment Management Group LLC (1.37M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.09M shares).
This table shows the top 276 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.